课题基金 / 基金详情

The relationship between disease progression and chemoresistance mediated by plasma gelsolin in epithelial ovarian cancer

The relationship between disease progression and chemoresistance mediated by plasma gelsolin in epithelial ovarian cancer
上皮性卵巢癌血浆凝溶胶蛋白介导的疾病进展与化疗耐药的关系
批准号：
476288
负责人：
Gerber Emma
金额：
$7.65万
依托单位：
Ottawa Hospital Research Institute
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-11-01 至 2025-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=476288&lang=en
关键词：
Biomarkers Cell Signaling Chemoresistance Epithelial Mesenchymal Transition Epithelial Ovarian Cancer Patient Survival Plasma Gelsolin Small Extracellular Vesicles Tumour Microenvironment

项目摘要

项目成果

Gerber Emma的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer due to diagnosis in advanced-stage disease and resistance to treatment. Previous work has shown that plasma gelsolin (pGSN) is a protein that plays an important role in EOC chemoresis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Combination of plasma gelsolin with radiological imaging for prognostication of ovarian cancer
  • 批准号：
    495885
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $0.44万
  • 财政年份：
    2023
  • 负责人：
    Gerber Emma
  • 依托单位：
    University of Hong Kong
Exploring the use of exosomal plasma gelsolin as a biomarker for early ovarian cancer diagnosis
  • 批准号：
    467118
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2021
  • 负责人：
    Gerber Emma
  • 依托单位：
    University of Ottawa
海外基金